Shareholders' Equity (Details) - Schedule of Awards Granted - shares |
9 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2023 |
[1] | Dec. 31, 2022 |
Dec. 31, 2021 |
|||
Schedule of Awards were Granted [Abstract] | ||||||
Expiration Date, Options | 5 years 4 months 2 days | 5 years 5 months 4 days | 6 years 3 months | |||
Options [Member] | ||||||
Schedule of Awards were Granted [Abstract] | ||||||
Number of Awards, Options | 167,779 | |||||
Vesting Conditions, Options | Over 4 years from grant date-25% every year | |||||
Expiration Date, Options | 10 years | |||||
RSU [Member] | ||||||
Schedule of Awards were Granted [Abstract] | ||||||
Number of Awards, RSU | 592,000 | |||||
Vesting Conditions, RSU | Over 3 years from grant date | |||||
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of reason for increase (decrease), classified as other, in number of awards under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Sets forth the nature of any other increase or decrease in the number of shares reserved for issuance under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares purchased for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|